Healthcare

The global healthcare market is highly complex, but it is one of the most compelling and impactful sectors we invest in. The healthcare market is constantly evolving in response to the challenges of the global disease burden as well as market forces such as increasing consumerization of healthcare services. At the same time, the discovery and adoption of new technologies are introducing innovation and opportunity into a system that has historically struggled with inefficiency and opacity.

Longstanding leaders in healthcare investing

In this complex environment, RTG’s focus remains simple—to build and grow companies that are adding value to the healthcare system and enabling better outcomes for patients. Over our 20-year history, we have partnered with founders and management teams to drive enduring growth and create products and services that have delivered breakthrough innovation, reduced costs, and expanded access to high-quality care.

RTG’s global healthcare franchise is led by one of the most experienced teams in private equity. The team invests thematically across strategies:

• Next-Generation and Value-Centric Care Delivery: Leading care delivery models that are expanding access to underserved populations, reducing healthcare costs through shifts in site of care and introducing patient-centric and risk-bearing solutions. Representative investments include Evolent Health, LifeStance Health, Kelsey-Seybold Clinic, Monogram Health, GoHealth, Zipline, and United Family Healthcare.
• Investing Behind Innovation: Pharmaceuticals, diagnostics and devices that represent step function innovations that transform patient outcomes, along with the essential enablers of such innovation. Representative investments include Allogene, AskBio, BVI, Novotech, and Precision for Medicine.
• Technology Enablement: Healthcare technology and related solutions that leverage the power of automation, data & analytics, and interoperability to improve care and patient choice in their own health. Representative investments include Dingdang Health, EnvisionRx, IQVIA, Q-Centrix, and WellSky.
• Investing for Transformation: Proprietary angles created by the RTG Healthcare team’s robust set of strategic and operational capabilities, including our deep industry knowledge and relationships, experience in building out executive teams and strategic roadmaps, and supporting operational resources and capabilities. Representative investments include Adare, Kindred at Home, Kindred Healthcare, Par Pharmaceutical, and Fenwal.